Alpha 1-acid Glycoprotein Concentrations and Propranolol Binding in Elderly Patients with Acute Illness

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1984 Nov 1

PMID 6508990

Citations 12

Authors

J W Paxton

R H Briant

Affiliations

Soon will be listed here.

Abstract

Alpha 1-acid glycoprotein (AAG) concentrations and propranolol binding were investigated in the serum of elderly hospitalized patients with acute illness, and healthy elderly and young subjects. Significantly greater AAG concentrations and reduced unbound propranolol fraction were observed in the elderly with acute disease compared to the elderly controls. The greatest changes (up to five-fold) occurred with cancer, with lesser changes associated with myocardial infarction and ischaemic heart disease, acute infection, heart failure, chronic obstructive respiratory disease, and cerebrovascular accident. Various miscellaneous conditions were also associated with high AAG concentrations and enhanced propranolol binding. The healthy elderly had higher AAG concentrations and lower unbound propranolol fractions than the healthy young group. Overall there was a highly significant correlation between the propranolol binding ratio (bound/free) and the serum AAG concentration. These results suggest that the elderly population may be particularly susceptible to changes in AAG concentrations, and that during acute illness interpretation of serum concentrations of drugs which bind mainly to AAG, may require knowledge of their free fractions.

Citing Articles

Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.

Berton M, Bettonte S, Stader F, Battegay M, Marzolini C Clin Pharmacokinet. 2022; 61(9):1251-1270.

PMID: 35699913 PMC: 9439993. DOI: 10.1007/s40262-022-01132-3.

Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Smith S, Waters N Pharm Res. 2018; 36(2):30.

PMID: 30593605 PMC: 7089466. DOI: 10.1007/s11095-018-2551-x.

Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Stader F, Siccardi M, Battegay M, Kinvig H, Penny M, Marzolini C Clin Pharmacokinet. 2018; 58(4):483-501.

PMID: 30128967 DOI: 10.1007/s40262-018-0709-7.

Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir.

Hickman D, Vasavanonda S, Nequist G, Colletti L, Kati W, Bertz R Antimicrob Agents Chemother. 2004; 48(8):2911-7.

PMID: 15273100 PMC: 478510. DOI: 10.1128/AAC.48.8.2911-2917.2004.

Diltiazem. A review of its pharmacology and therapeutic use in older patients.

Markham A, Brogden R Drugs Aging. 1993; 3(4):363-90.

PMID: 8369596 DOI: 10.2165/00002512-199303040-00007.

References

Booker H, Darcey B . Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication. Epilepsia. 1973; 14(2):177-84. DOI: 10.1111/j.1528-1157.1973.tb03954.x. View

Paxton J . Alpha 1 -acid glycoprotein and binding of basic drugs. Methods Find Exp Clin Pharmacol. 1983; 5(9):635-48. View

McDevitt D, Frisk-Holmberg M, Hollifield J, SHAND D . Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther. 1976; 20(2):152-7. DOI: 10.1002/cpt1976202152. View

Borga O, Piafsky K, Nilsen O . Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther. 1977; 22(5 Pt 1):539-44. View

Piafsky K, Borga O, Odar-Cederlof I, Johansson C, Sjoqvist F . Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978; 299(26):1435-9. DOI: 10.1056/NEJM197812282992604. View

Woo E, Greenblatt D . Pharmacokinetic and clinical implications of quinidine protein binding. J Pharm Sci. 1979; 68(4):466-70. DOI: 10.1002/jps.2600680419. View

Meffin P, Robert E, Winkle R, Harapat S, Peters F, Harrison D . Role of concentration-dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm. 1979; 7(1):29-46. DOI: 10.1007/BF01059439. View

Wiegand U, Hintze K, Slattery J, Levy G . Protein binding of several drugs in serum and plasma of healthy subjects. Clin Pharmacol Ther. 1980; 27(3):297-300. DOI: 10.1038/clpt.1980.39. View

Routledge P, Stargel W, Wagner G, SHAND D . Increased plasma propranolol binding in myocardial infarction. Br J Clin Pharmacol. 1980; 9(4):438-40. PMC: 1429969. DOI: 10.1111/j.1365-2125.1980.tb01077.x. View

10.

DENKO C, Gabriel P . Age and sex related levels of albumin, ceruloplasmin, alpha 1 antitrypsin, alpha 1 acid glycoprotein, and transferrin. Ann Clin Lab Sci. 1981; 11(1):63-8. View

11.

Chapelle J, Albert A, Smeets J, HEUSGHEM C, Kulbertus H . The prognostic significance of serum alpha 1-acid glycoprotein changes in acute myocardial infarction. Clin Chim Acta. 1981; 115(2):199-209. DOI: 10.1016/0009-8981(81)90076-0. View

12.

Lima J, Boudoulas H, Blanford M . Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. J Pharmacol Exp Ther. 1981; 219(3):741-7. View

13.

Abramson F . Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein. Clin Pharmacol Ther. 1982; 32(5):652-8. DOI: 10.1038/clpt.1982.217. View

14.

Huang J, Oie S . Effect of altered disopyramide binding on its pharmacologic response in rabbits. J Pharmacol Exp Ther. 1982; 223(2):469-71. View

15.

Paxton J, Calder R . Propranolol binding in serum: comparison of methods and investigation of effects of drug concentration, pH, and temperature. J Pharmacol Methods. 1983; 10(1):1-11. DOI: 10.1016/0160-5402(83)90009-8. View

16.

Tozer T, Gambertoglio J, Furst D, Avery D, Holford N . Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans. J Pharm Sci. 1983; 72(12):1442-6. DOI: 10.1002/jps.2600721218. View

17.

Kunin C, Craig W, Kornguth M, Monson R . Influence of binding on the pharmacologic activity of antibiotics. Ann N Y Acad Sci. 1973; 226:214-24. DOI: 10.1111/j.1749-6632.1973.tb20483.x. View